Oxygen therapy has become an indispensable treatment modality across multiple medical fields, including critical care, chronic respiratory diseases, and emergency medicine. The rising prevalence of respiratory disorders such as COPD, COVID-19 complications, and sleep apnea has intensified demand for oxygen delivery systems, driving significant advancements in devices and therapeutics. The Global Oxygen Therapy Market size is estimated to be valued at USD 8.5 billion in 2025 and is expected to reach USD 14.2 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032. This growth trajectory is underpinned by expanding geriatric populations, increasing adoption of homecare oxygen devices, and the integration of smart technologies enhancing patient compliance and treatment efficacy.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/97
➤Actionable Insights
● Production capacity in oxygen delivery systems increased by 15% globally in 2024, driven by demand surges in North America and Asia Pacific.
● Pricing dynamics observed a moderate rise of 4% due to raw material constraints and innovation costs focused on portable oxygen concentrators.
● Exports of oxygen therapy equipment showed a 20% rise in 2024, with emerging economies boosting imports to cater to chronic respiratory disease management.
● Demand-side analysis reveals that hospital and homecare sectors together accounted for over 80% of oxygen therapy device utilization in 2024, underscoring diverse end-user applications.
● Micro-indicators such as rising per capita oxygen consumption in elder care homes and nano-level trends like wearable oxygen sensors contributed cumulatively to market size expansion.
➤Market Segment and Regional Coverage
● By Product Type: Portable Oxygen Concentrators, Stationary Oxygen Concentrators, Oxygen Cylinders, Oxygen Delivery Accessories, and Others.
● By End-User: Hospitals, Homecare, Ambulatory Surgical Centers, and Emergency Services.
● By Technology: Continuous Flow Oxygen Therapy, Pulse Dose Technology, and Hybrid Systems.
Regional and Country Analysis:
● North America: U.S. and Canada
● Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
● Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
● Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
● Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA
➤Key Players
● Medtronic plc
● Philips Healthcare
● ResMed Inc.
● Invacare Corporation
● Inogen Inc.
● CAIRE Inc.
● Air Liquide Healthcare
● Chart Industries, Inc.
● Linde Healthcare
● Fisher & Paykel Healthcare
● Drive DeVilbiss Healthcare
● Becton, Dickinson and Company
● O2 Concepts, Inc.
● OMRON Healthcare
● Hamilton Medical AG
● Teijin Limited
● Nidek Medical Products
● Nipro Corporation
● Drive Medical
● Caire Inc.
Significant competitive strategies include Medtronic’s recent acquisition of AirSep Corporation to consolidate its position in oxygen concentrator technology, resulting in a 12% revenue uplift in 2024. Philips Healthcare’s collaboration with technology firms on AI-driven oxygen delivery systems improved patient adherence by over 18%, enhancing its market share in the homecare segment.
Get Full Report: https://www.coherentmarketinsights.com/market-insight/oxygen-therapy-market-97?utm_source=newstrail.com&utm_medium=referral
➤Growth factors
● The surge in chronic respiratory diseases accounted for a 10% rise in oxygen therapy adoption worldwide in 2024.
● The geriatric population aged 60 and above surpassed 1.2 billion globally, increasing oxygen therapy demand in homecare settings.
● The COVID-19 pandemic accelerated market growth by fostering infrastructure enhancements in oxygen supply chains and portable system innovations.
● Increasing health awareness and reimbursement policies in countries like the U.S. and Germany stimulated sustained business growth in the Oxygen Therapy Market revenue.
➤ Market Trends
● Technological advancements, such as integration of IoT and wearable oxygen monitors, are redefining market dynamics by improving real-time patient monitoring.
● Growing preference towards portable oxygen concentrators is replacing traditional oxygen cylinders due to convenience and mobility benefits, with a 25% sales increase in 2024.
● Expansion of telehealth combined with remote oxygen management systems is creating new market opportunities, especially in developed regions.
● Sustainable and eco-friendly oxygen delivery systems are gaining traction, driven by global regulatory frameworks targeting carbon neutrality in healthcare.
➤Key Takeaways
● The stationary oxygen concentrator segment dominates the product category due to wide hospital utilization and ongoing technological upgrades.
● Homecare end-user segment is poised for robust growth owing to rising chronic disease cases and improved insurance coverage.
● Pulse dose technology under technology segmentation is gaining momentum for its efficiency and battery-saving features.
● North America remains a key region, led by healthcare infrastructure investments and advanced reimbursement models.
● Asia Pacific is a rapidly emerging market leveraging growing patient awareness and expanding healthcare access.
● Europe benefits from stringent regulatory standards fostering innovative oxygen therapy products and expanding market scope.
📌 Get Instant Access! Purchase Research Report and Receive a 25% Discount with limited-time offer! https://www.coherentmarketinsights.com/insight/buy-now/97
❓ Frequently Asked Questions
1. Who are the dominant players in the Oxygen Therapy Market?
The Oxygen Therapy Market is led by key companies including Medtronic plc, Philips Healthcare, ResMed Inc., Invacare Corporation, and Inogen Inc., all of which employ innovative strategies to expand product portfolios and market presence.
2. What will be the size of the Oxygen Therapy Market in the coming years?
The Oxygen Therapy Market size is projected to reach USD 14.2 billion by 2032, growing at a CAGR of 7.8% from 2025 to 2032, driven primarily by rising respiratory diseases and technological advancements.
3. Which end-user industry has the largest growth opportunity?
The homecare segment holds the largest growth opportunity in the Oxygen Therapy Market due to increasing chronic respiratory conditions and the adoption of portable oxygen concentrators.
4. How will market development trends evolve over the next five years?
Market trends will focus on smart oxygen delivery devices, increased telehealth integration, sustainable product innovation, and expansion in emerging economies impacting overall market growth positively.
5. What is the nature of the competitive landscape and challenges in the Oxygen Therapy Market?
The competitive landscape is characterized by mergers, acquisitions, and technology-centric innovation, while challenges include regulatory compliance, supply chain management, and cost constraints.
6. What go-to-market strategies are commonly adopted in the Oxygen Therapy Market?
Players adopt strategies such as strategic partnerships, product diversification, geographic expansion, and investment in R&D to advance market share and revenue streams.
✍️ PR Authored By:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report.
About Us:
With a proven excellence in market research, Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
☎️ Contact Us:
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-2-4786-0457
India: +91-848-285-0837
Email: [email protected]
